{"id":7948,"date":"2024-04-01T16:34:43","date_gmt":"2024-04-01T14:34:43","guid":{"rendered":"https:\/\/shams-alyaoum.com\/en\/?p=7948"},"modified":"2024-04-01T16:34:43","modified_gmt":"2024-04-01T14:34:43","slug":"kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer","status":"publish","type":"post","link":"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/","title":{"rendered":"KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer"},"content":{"rendered":"
\n
<\/div>\n
\n
\n
\n

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Peter Carbone as the new Chief Quality Officer, strengthening KBI\u2019s expertise in Quality and Regulatory Affairs.<\/p>\n

A highly respected and successful industry leader, Peter brings over 35 years of experience in operations, quality, and technology leadership in a diverse range of areas in the life sciences spectrum, including biotechnology, pharmaceuticals, and advanced therapies. Peter will lead KBI\u2019s Quality and Regulatory Affairs team, spearheading compliance and regulatory initiatives for customers worldwide and positioning KBI to provide the services, expertise, and leadership to partner with health authorities on regulatory policy.<\/p>\n

“We have made a commitment to establishing KBI Biopharma as a thought leader and catalyst for change in Regulatory Affairs within the biopharma sector,\u201d said J.D. Mowery, President & CEO of KBI Biopharma. “Peter’s addition to our team bolsters our expertise in quality and regulatory compliance and facilitates our continued transformation in support of our current and future customers. His passion for making a difference in the world, coupled with his drive to develop and deliver innovative products that improve patients\u2019 lives, makes him an invaluable asset to KBI.\u201d<\/p>\n

\u201cI am thrilled to join KBI Biopharma during a time of significant evolution for the company,\u201d said Peter Carbone, Chief Quality Officer of KBI Biopharma. \u201cWe are poised for remarkable advancements in the biopharma industry, and I look forward to working with this talented team to drive innovation, ensure quality, deliver exceptional results, and ultimately make a meaningful impact on patients\u2019 lives worldwide.\u201d<\/p>\n

Prior to joining KBI, Peter led engineering, operations, and quality organizations at major pharmaceutical companies, including Bayer, Amgen, Allergan, Novartis, Acorda, and the Center of Breakthrough Medicines. He holds a BS in Chemical Engineering from Rensselaer Polytechnic Institute.<\/p>\n

About KBI Biopharma, Inc.<\/b><\/p>\n

KBI Biopharma, Inc., a JSR Life Sciences company, together with its affiliates, is a global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. As a global leader in mammalian cell line development, with best-in-class modular technology and highly specialized solutions, KBI enables the life sciences industry to rapidly discover, develop and commercialize innovative medicines and vaccines. With each of its 500+ client partners, KBI works closely to personalize and rapidly accelerate drug development programs.<\/p>\n

Global partners are utilizing KBI\u2019s technologies to advance more than 160 drug candidates in preclinical and clinical development and the manufacture of ten commercial products. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, KBI delivers robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, KBI helps partners advance drug candidates to the market. KBI serves its global partners with eight locations in Europe and the USA. More information is available at\u00a0www.kbibiopharma.com<\/a>.<\/p>\n

 <\/p>\n<\/div>\n

<\/div>\n
\n

Contacts<\/h3>\n
\n
\n

KBI Biopharma, Inc. Company Inquiries
\nSarah Wakefield
\nKBI Biopharma, Inc.
\nswakefield@kbibiopharma.com<\/a><\/p>\n<\/div>\n

\n
\n

KBI Biopharma, Inc. Media Inquiries
\nKelly Biele
\nCG Life
\nkbiele@cglife.com<\/a><\/p>\n<\/div>\n<\/div>\n

\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n
<\/div>\n<\/div>\n
\n
\n
\n
<\/i>\u00a0PREVIOUS POST<\/a><\/div>\n
Blue Yonder Announces Binding Agreement To Acquire One Network Enterprises for Approximately $839 Million To Create Multi-Enterprise Supply Chain Ecosystem<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n
\n
<\/div>\n
<\/div>\n<\/div>\n
\n
\n
\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Peter Carbone as the new Chief Quality Officer, strengthening KBI\u2019s expertise in Quality and Regulatory Affairs. A highly respected and successful industry leader, Peter brings over 35 years of experience in operations, quality, …<\/p>\n","protected":false},"author":1,"featured_media":7949,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[28],"tags":[],"class_list":["post-7948","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company"],"yoast_head":"\nKBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer - Magazine Shams Al Yaoum<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer - Magazine Shams Al Yaoum\" \/>\n<meta property=\"og:description\" content=\"KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Peter Carbone as the new Chief Quality Officer, strengthening KBI\u2019s expertise in Quality and Regulatory Affairs. A highly respected and successful industry leader, Peter brings over 35 years of experience in operations, quality, …\" \/>\n<meta property=\"og:url\" content=\"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Magazine Shams Al Yaoum\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-01T14:34:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2024\/04\/peter-carbone.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"512\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/\",\"url\":\"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/\",\"name\":\"KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer - Magazine Shams Al Yaoum\",\"isPartOf\":{\"@id\":\"https:\/\/shams-alyaoum.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2024\/04\/peter-carbone.jpg\",\"datePublished\":\"2024-04-01T14:34:43+00:00\",\"author\":{\"@id\":\"https:\/\/shams-alyaoum.com\/en\/#\/schema\/person\/2a6e250733a79a0dfa8f565d33453404\"},\"breadcrumb\":{\"@id\":\"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/#primaryimage\",\"url\":\"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2024\/04\/peter-carbone.jpg\",\"contentUrl\":\"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2024\/04\/peter-carbone.jpg\",\"width\":1024,\"height\":512},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/shams-alyaoum.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/shams-alyaoum.com\/en\/#website\",\"url\":\"https:\/\/shams-alyaoum.com\/en\/\",\"name\":\"Magazine Shams Al Yaoum\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/shams-alyaoum.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/shams-alyaoum.com\/en\/#\/schema\/person\/2a6e250733a79a0dfa8f565d33453404\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/shams-alyaoum.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/12142290755ac4167421ec285a9e9bfe4d47e152df768c413576a5f88250adab?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/12142290755ac4167421ec285a9e9bfe4d47e152df768c413576a5f88250adab?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"http:\/\/localhost\/shamsalyaoumfr\"],\"url\":\"https:\/\/shams-alyaoum.com\/en\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer - Magazine Shams Al Yaoum","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/","og_locale":"en_US","og_type":"article","og_title":"KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer - Magazine Shams Al Yaoum","og_description":"KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Peter Carbone as the new Chief Quality Officer, strengthening KBI\u2019s expertise in Quality and Regulatory Affairs. A highly respected and successful industry leader, Peter brings over 35 years of experience in operations, quality, …","og_url":"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/","og_site_name":"Magazine Shams Al Yaoum","article_published_time":"2024-04-01T14:34:43+00:00","og_image":[{"width":1024,"height":512,"url":"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2024\/04\/peter-carbone.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/","url":"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/","name":"KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer - Magazine Shams Al Yaoum","isPartOf":{"@id":"https:\/\/shams-alyaoum.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/#primaryimage"},"image":{"@id":"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2024\/04\/peter-carbone.jpg","datePublished":"2024-04-01T14:34:43+00:00","author":{"@id":"https:\/\/shams-alyaoum.com\/en\/#\/schema\/person\/2a6e250733a79a0dfa8f565d33453404"},"breadcrumb":{"@id":"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/#primaryimage","url":"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2024\/04\/peter-carbone.jpg","contentUrl":"https:\/\/shams-alyaoum.com\/en\/wp-content\/uploads\/2024\/04\/peter-carbone.jpg","width":1024,"height":512},{"@type":"BreadcrumbList","@id":"https:\/\/shams-alyaoum.com\/en\/kbi-biopharma-strengthens-quality-and-regulatory-affairs-expertise-with-appointment-of-chief-quality-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/shams-alyaoum.com\/en\/"},{"@type":"ListItem","position":2,"name":"KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer"}]},{"@type":"WebSite","@id":"https:\/\/shams-alyaoum.com\/en\/#website","url":"https:\/\/shams-alyaoum.com\/en\/","name":"Magazine Shams Al Yaoum","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/shams-alyaoum.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/shams-alyaoum.com\/en\/#\/schema\/person\/2a6e250733a79a0dfa8f565d33453404","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/shams-alyaoum.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/12142290755ac4167421ec285a9e9bfe4d47e152df768c413576a5f88250adab?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/12142290755ac4167421ec285a9e9bfe4d47e152df768c413576a5f88250adab?s=96&d=mm&r=g","caption":"admin"},"sameAs":["http:\/\/localhost\/shamsalyaoumfr"],"url":"https:\/\/shams-alyaoum.com\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/posts\/7948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/comments?post=7948"}],"version-history":[{"count":1,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/posts\/7948\/revisions"}],"predecessor-version":[{"id":7950,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/posts\/7948\/revisions\/7950"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/media\/7949"}],"wp:attachment":[{"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/media?parent=7948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/categories?post=7948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/shams-alyaoum.com\/en\/wp-json\/wp\/v2\/tags?post=7948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}